chitosan has been researched along with Herpes Simplex Virus Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, TA; Al-Subaie, MM; Aljaeid, BM; El-Say, KM; Hosny, KM | 1 |
| Anower, AK; Choi, B; Islam, SM; Jo, DH; Sohn, S | 1 |
2 other study(ies) available for chitosan and Herpes Simplex Virus Infection
| Article | Year |
|---|---|
Utilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infections.
Topics: Acyclovir; Animals; Biological Availability; Chitosan; Eugenol; Herpes Simplex; Hydrogels; Male; Models, Theoretical; Molecular Weight; Nanoparticles; Nanotechnology; Particle Size; Rats; Rats, Wistar; Skin; Skin Absorption | 2015 |
Chitosan as an Immunomodulating Adjuvant on T-Cells and Antigen-Presenting Cells in Herpes Simplex Virus Type 1 Infection.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Antigen-Presenting Cells; Chitosan; Crustacea; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Green Fluorescent Proteins; Herpes Simplex; Herpesvirus 1, Human; Immunoglobulin G; Leukocytes, Mononuclear; Male; Mice; Mice, Inbred ICR; Monocytes; Receptors, Interleukin-15; Receptors, Interleukin-7; T-Lymphocytes | 2016 |